On 19 March 2020, the Centre for Biosimilars reported on a pair of biosimilar bills which were introduced to the US Congress in the 2 weeks prior. These bills include a ‘shared savings’ model designed to encourage physicians to switch patients to biosimilars, and a program that would allow $0 co-pays for seniors prescribed biosimilars.
Home / News / Pearce IP Blog
Centre for Biosimilars reports biosimilar bills introduced to US Congress
Get our Pearce IP Blogs & BioBlast® sent directly to your inbox
Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.